An2 Therapeutics, INC. (ANTX) — DEF 14A Filings

All DEF 14A filings from An2 Therapeutics, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (2)

AN2 Therapeutics Files 2025 Proxy Statement — Apr 10, 2025 Risk: low
AN2 Therapeutics, Inc. filed its definitive proxy statement on April 10, 2025, for the fiscal year ending December 31, 2024. The filing, designated as DEF 14A,
AN2 Therapeutics, Inc. Announces 2024 Annual Meeting of Stockholders on June 19, 2024 — Apr 26, 2024 Risk: low
AN2 Therapeutics, Inc. (ANTX) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. AN2 Therapeutics, Inc. will hold its 2024 Annual Meeting of Stoc

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX